| 1 |
16129418 | Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954. | 2005 Oct 14 |
1 |
| 2 |
14529407 | CB 1954: from the Walker tumor to NQO2 and VDEPT. | 2003 |
1 |
| 3 |
11361019 | Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model. | 2001 Jan 1 |
1 |
| 4 |
10419545 | Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling. | 1999 Aug |
1 |
| 5 |
10543876 | Crystal structure of human DT-diaphorase: a model for interaction with the cytotoxic prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954). | 1999 Oct 21 |
2 |
| 6 |
10656629 | Role of redox cycling and activation by DT-diaphorase in the cytotoxicity of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB-1954) and its analogs. | 1999 Nov 15 |
7 |
| 7 |
9367528 | Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. | 1997 Nov 15 |
1 |
| 8 |
8375021 | The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). | 1993 Jun |
1 |
| 9 |
1449531 | Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity. | 1992 Nov 3 |
2 |
| 10 |
1901207 | The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide) | 1991 Mar 15-Apr 1 |
7 |